Qiligeer Bao
-
- Blood Pressure and Hypertension Studies 6
- Cardiovascular Health and Disease Prevention 6
- Cardiovascular Function and Risk Factors 3
- Cardiovascular Disease and Adiposity 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Liver Disease Diagnosis and Treatment 2
-
- Nutritional Studies and Diet 2
-
- Cerebrovascular and Carotid Artery Diseases 2
- Journals
- Journal of Clinical Hypertension (3 papers)Scientific Reports (2 papers)BMC Geriatrics (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Qiligeer Bao
18 papers receiving 228 citations
Peers
Comparison fields: 5 of 52
- Cardiology and Cardiovascular Medicine 94
- Endocrinology, Diabetes and Metabolism 67
- Nephrology 22
- Geriatrics and Gerontology 9
- Physiology 44
Countries citing papers authored by Qiligeer Bao
This map shows the geographic impact of Qiligeer Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiligeer Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiligeer Bao more than expected).
Fields of papers citing papers by Qiligeer Bao
This network shows the impact of papers produced by Qiligeer Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiligeer Bao. The network helps show where Qiligeer Bao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiligeer Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 15 | |
| 10 | 2022 | 32 | |
| 11 | 2022 | 23 | |
| 12 | 2022 | 60 | |
| 13 | 2022 | 25 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 11 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 16 | |
| 19 | 2021 | 26 | |
| 20 | 2018 | 1 |
About Qiligeer Bao
Qiligeer Bao is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 21 papers that have together received 230 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Cardiovascular Health and Disease Prevention (6 papers), Cardiovascular Function and Risk Factors (3 papers), Cardiovascular Disease and Adiposity (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Nutritional Studies and Diet (2 papers) and Cerebrovascular and Carotid Artery Diseases (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (94 citations), Endocrinology, Diabetes and Metabolism (67 citations) and Nephrology (22 citations). Qiligeer Bao has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Shuang Cai, Bokai Cheng, Anhang Zhang, Shouyuan Ma, Yongkang Su, Shuxia Wang, Jin Sun, Man Li, Yan Zhang and Man Li. Their work appears in journals such as Journal of Clinical Hypertension, Scientific Reports, BMC Geriatrics, Frontiers in Cardiovascular Medicine and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.